SCHEDULE: Seven Fleet Funds Adjust Entera Bio Stake

Seven Fleet Horizon Master Fund LP, Seven Fleet Master Fund LP, Seven Fleet Capital Management LP, Seven Fleet Capital Management GP LLC, and Brian Liu have collectively reported a change in their beneficial ownership of Entera Bio, Ltd. ordinary shares.

Summary

• This filing reports a change in beneficial ownership of Entera Bio, Ltd. ordinary shares by several Seven Fleet entities and Brian Liu.
• Seven Fleet Horizon Master Fund LP now beneficially owns 1,960,784 shares, representing 1.1% of the class.
• Seven Fleet Master Fund LP now beneficially owns 5,093,114 shares, representing 3.0% of the class.
• Seven Fleet Capital Management LP, Seven Fleet Capital Management GP LLC, and Brian Liu collectively beneficially own 7,053,898 shares, representing 4.1% of the class.
• The total outstanding ordinary shares of Entera Bio, Ltd. as of July 28, 2026, were 172,251,411.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without disclosing new strategic information or financial performance.

Positives

• The filing clearly outlines the beneficial ownership stakes held by the Seven Fleet entities and Brian Liu.
• The reporting is based on information provided by the Issuer regarding outstanding shares, ensuring a factual basis for percentage calculations.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Entera Bio, Ltd.
• The disclaimer regarding group membership and beneficial ownership suggests potential complexities or disagreements in ownership attribution.

Risks

• The disclaimer that the Reporting Persons expressly disclaim group membership and beneficial ownership over certain shares could indicate potential disputes or complexities in ownership structure.
• The filing does not offer insights into the strategic direction or financial health of Entera Bio, Ltd., leaving investors to seek this information elsewhere.

Future Outlook

No forward-looking statements or guidance are provided in this Schedule 13G filing.

Management Comments

• The Reporting Persons expressly disclaim group membership and beneficial ownership over any Ordinary Shares that they may be deemed to beneficially own by reason of such policies and procedures.
• This Schedule 13G shall not be deemed an admission that the Reporting Persons are members of a group for purposes of Section 13 of the Exchange Act or for any other purpose.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically report changes in beneficial ownership by institutional investors. This filing indicates an adjustment in holdings by Seven Fleet entities, which is common in the biotechnology sector where significant stakes can be held by investment funds.

Stakeholder Impact

• Shareholders may note the increased aggregate stake held by the Seven Fleet entities, which could influence market perception or future corporate actions.
• The disclaimer regarding group membership might signal potential future scrutiny or require clarification from the reporting persons.

Next Steps

• Monitor future filings from Seven Fleet entities for any further changes in beneficial ownership.
• Seek separate disclosures from Entera Bio, Ltd. for financial performance and strategic updates.

Key Dates

Keywords

Entera Bio, Seven Fleet, Beneficial Ownership, Schedule 13G, Ordinary Shares, Investment Management, Cayman Islands, Delaware